A blood collection device recently patented by Biodesix, Boulder, Colo, makes collecting blood samples easier. The new device can also reduce the costs and environmental impact of shipping blood tubes and related cold-chain logistics.

Currently in use with the Biodesix Nodify XL2 test, the blood collection device eliminates the need for onsite processing of samples used for proteomic testing and for shipping blood tubes, which often requires cold-chain logistics during transit to the testing laboratory. The device reduces the need for processing equipment such as centrifuges; improves sample stability during transit; and eliminates the need for bulky, single-use shipping containers containing materials such as Styrofoam, which are costly and have a negative environmental impact.


Susan Garwood, MD, Centennial Medical Center.

“This device is intuitive and very easy to use,” says Susan Garwood, MD, a pulmonary and advanced bronchoscopy lung cancer specialist at Centennial Medical Center. “The Biodesix collection device enables a fast, simple collection process. Enhancing patient comfort while retaining accuracy is of top concern for all professionals drawing patient blood samples.”

Biodesix is planning to use its new blood collection device in all current and future proteomic testing and will also make the device available for purchase by labs and diagnostic companies wishing to use the technology for their own sample processing and testing.

For further information, visit Biodesix.